Company chart and information is provided by TradingView based on 15-minute-delayed data.
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.
| Website: | www.verupharma.com |
| Email: | veruinvestor@verupharma.com |
| Main Phone: | +1 305 509-6897 |
| Address: | 48 NW 25th Street |
| Address 2: | Suite 102 |
| State: | FL |
| City / Town: | Miami |
| Country: | US |
| Postal Code: | 33137 |
| Exchange: | NSC |
| CEO: | Mitchell S. Steiner |
| Employees: | 339 |
| NAICS: | Research and Development in Nanotechnology(541713) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
